Last week, the genomic start-up company Navigenics issued a press release introducing their team of advisors and investors, and announcing $25 million in financing. There was an accompanying story in the Wall Street Journal, “Is There a Heart Attack in Your Future?” According to the article, the tests that will eventually be offered by Navigenics have already been tested by at least one of the company’s co-founders:
“David Agus, a cancer researcher at Cedars-Sinai Medical Center in Los Angeles who is a co-founder of the company, says he took the test and found he had a 68% risk of having a heart attack in his lifetime, compared with about 40% in the general population. His kids, he says, now help him stay away from French fries. “I’m a believer in empowerment,” he says.”